Ardent Health Partners/$ARDT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Ardent Health Partners
Ardent Health Inc is a provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in services and technologies, Ardent is passionate about making healthcare easier to access.
Ticker
$ARDT
Sector
Primary listing
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
22,050
ISIN
US03980N1072
Website
ARDT Metrics
BasicAdvanced
$1.9B
8.12
$1.64
-
-
Price and volume
Market cap
$1.9B
52-week high
$17.34
52-week low
$11.31
Average daily volume
280K
Financial strength
Current ratio
2.122
Quick ratio
1.605
Long term debt to equity
144.361
Total debt to equity
145.497
Interest coverage (TTM)
6.56%
Profitability
EBITDA (TTM)
544.166
Gross margin (TTM)
57.32%
Net profit margin (TTM)
3.73%
Operating margin (TTM)
6.59%
Effective tax rate (TTM)
17.83%
Revenue per employee (TTM)
$270,000
Management effectiveness
Return on assets (TTM)
5.22%
Return on equity (TTM)
23.35%
Valuation
Price to earnings (TTM)
8.123
Price to revenue (TTM)
0.3
Price to book
1.62
Price to tangible book (TTM)
8.59
Price to free cash flow (TTM)
15.287
Free cash flow yield (TTM)
6.54%
Free cash flow per share (TTM)
87.07%
Growth
Revenue change (TTM)
8.91%
Earnings per share change (TTM)
938.13%
Bulls say / Bears say
Ardent Health Partners reported a 4% increase in total revenue for Q1 2025, reaching $1.497 billion, indicating strong financial performance. (ardenthealth.com)
Analysts have assigned a consensus 'Buy' rating to Ardent Health Partners, with an average price target of $21.18, suggesting potential upside from the current price. (defenseworld.net)
The company has demonstrated operational efficiency with a 7.6% increase in admissions and a 9.5% rise in patient days in Q1 2025, reflecting growing patient demand. (ardenthealth.com)
Ardent Health Partners priced its IPO below the targeted range, raising $192 million instead of the anticipated amount, which may indicate weaker investor confidence. (reuters.com)
The company's net income for 2023 more than halved to approximately $129 million, raising concerns about profitability despite revenue growth. (reuters.com)
Ardent Health Partners' stock is currently trading at $14.66, below the average analyst price target of $21.18, suggesting potential undervaluation or market skepticism. (defenseworld.net)
Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2025.
ARDT News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Ardent Health Partners stock?
Ardent Health Partners (ARDT) has a market cap of $1.9B as of June 27, 2025.
What is the P/E ratio for Ardent Health Partners stock?
The price to earnings (P/E) ratio for Ardent Health Partners (ARDT) stock is 8.12 as of June 27, 2025.
Does Ardent Health Partners stock pay dividends?
No, Ardent Health Partners (ARDT) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next Ardent Health Partners dividend payment date?
Ardent Health Partners (ARDT) stock does not pay dividends to its shareholders.
What is the beta indicator for Ardent Health Partners?
Ardent Health Partners (ARDT) does not currently have a Beta indicator.